SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (965)10/1/1999 12:13:00 PM
From: BiomavenRead Replies (1) of 4974
 
Rick,

I'm also an NPSP fan - it's not a "7" in your terms, but it's more than a smidge, not having the extreme risk associated with stocks like CTII and RGEN. Stock certainly hasn't done much to date, as AMGN ambles along with the calcimimetic trials.

I think trying to pick 50-100X stocks is a poor investment strategy in biotechland. It mostly means you are investing in pico-caps that have a distant shot at a big indication. My own view is that you should shoot for the 5-10x stocks.

However if you are going to make us play the 50-100X game, then GZMO probably has as good a shot as anyone.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News